Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?

OBJECTIVE: Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag. Antinuclear antibody (ANA) positivity can be seen at rates of up to 30% in ITP patients. Despi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baysal, Mehmet, Baş, Volkan, Ümit, Elif, Kırkızlar, Hakkı Onur, Demir, Ahmet Muzaffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886267/
https://www.ncbi.nlm.nih.gov/pubmed/34162172
http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886267/
https://www.ncbi.nlm.nih.gov/pubmed/34162172
http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0183

Ejemplares similares